We wish to thank the following organizations that are participating as exhibitors.

The materials they provide are independent of the CME program and not part of the CME educational materials. These entities did not influence or determine the content of AAP Colorado’s 2023 Annual Conference. Participation in the exhibits is optional and encouraged.

Amazing Care Home Health Services is an industry leader in providing safe, effective, and quality skilled home health for individuals of all ages and various care needs. We believe that the key to attaining the highest level of patient care is outstanding staff satisfaction.  As a full-service home health provider, Amazing Care stands out among our peers in emphasizing a comprehensive patient-centered care model.  We offer a variety of services to meet the needs of patients and their families; RN, PT, OT, ST, CNA and MSW.  We also have private duty nursing, IHSS (In Home Support Services) and Family Provider CNA programs.  By providing a full suite of collaborative services, we are able to meet a family’s needs under one roof.

Autism Learning Partners (ALP) is an ABA industry leader and nationwide provider in evidence-based, family-oriented autism therapies. For over 30 years, ALP has been specializing in the treatment of developmental disabilities while providing customized care plans for individuals with autism and their family. Support is provided in a variety of settings including in-center, in-home, school, and community. ALP collaborates with local community partners such as doctors, therapists, families, schools and specialists for comprehensive, effective care. Our goal is to work together to achieve the best possible outcome for each child. We accept most major insurance plans, including Medicaid. We provide services in English, Spanish, and more upon request. Visit our website at www.AutismLearningPartners.com or email us at Intake@AutismLearningPartners.com.

At Behavioral Innovations, we believe quality ABA therapy should be available to children who will benefit from this service. Applied behavior analysis or ABA therapy utilizes long-established principles of behavior therapy to identify and address the specific needs of children with autism or autism spectrum disorder (ASD).   For more than 20 years, the team at Behavioral Innovations has been guided by this mission to provide client-centered, evidence-based ABA therapy for children with autism in a nurturing learning environment.   We are trusted by parents and recommended by clinicians in all areas we serve.

For information contact Jennie Wurst, MS, RD at jwurst@bmrn.com, or visit https://www.biomarin.com/.

At Children’s Hospital Colorado, we see more, treat more and heal more kids than any hospital in our seven-state region. We’re experienced and forward-thinking when it comes to the latest methods for diagnosis and treatment. This translates into less invasive treatment, less time, and less stress on families and patients. We are the only dedicated Level 1 trauma center in the region, handling the most challenging emergencies. Our affiliation with the University of Colorado School of Medicine means that our doctors are not only expert clinicians, but also active researchers working toward better ways to care for kids. We partner with community providers to make them an essential member of our integrated team that’s committed to delivering the best possible treatment across the continuum of care. For more information, visit https://www.childrenscolorado.org.

The Colorado Immunization Branch, at the Colorado Department of Public Health and Environment, works to reduce vaccine-preventable disease by developing and implementing programs designed to positively influence the uptake of immunizations across the lifespan. The Immunization Branch utilizes a variety of strategies to promote education, optimize vaccine resources, assure access to vaccines and maintain the Colorado Immunization Information System (CIIS), a confidential, population-based, computerized information system that collects and consolidates immunization data for Coloradans of all ages from a variety of sources and provides tools for designing and sustaining effective immunization strategies at the provider and program levels. The Immunization Branch also operates the Federal Vaccines for Children (VFC) program, the Federal Section 317 program, and all immunization education and outreach activities. Learn more by visiting the organization’s website here

The Colorado Newborn Bloodspot Screening Program (CONBSP) improves newborn’s lives through early detection of 39 life-threatening genetic disorders for all Colorado and Wyoming newborns. The program is a part of the Colorado State Public Health Laboratory within the Division of Disease Control and Public Health Response (DCPHR) at CDPHE. The CONBSP is required by statute to operate 6 days a week including holidays in order to ensure timely reporting of abnormal results.  Annually, there are approximately 68,000 births in Colorado and Wyoming. Currently, there are requests that come from over 800 unique submitters. This translates into reporting more than 130,000 samples using 9 different testing methods for more than 700,000 individual tests annually. Babies with these conditions often appear normal at birth but could develop signs and symptoms later in life. There are 700 affected children identified each year due to this testing in Colorado, making it one of the most successful public health campaigns in terms of both cost and prevention. For more information please visit CONBSP’s website or contact us at 303-692-3675.

Colorado Pediatric Psychiatry Consultation & Access Program (CoPPCAP) provides consultation at no cost to pediatric care providers by licensed child & adolescent psychiatrists, psychologists, and specialized community resource navigators. Learn more by visiting the organization’s website here. Contact: Kristin Larpenter,  Info@coppcap.org, 1-888-910-0153.

GSK unites science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines.

Healthy Young Minds (HYM) is Redefining the Traditional Therapy Model Online. We founded Healthy Young Minds with the belief that every child should have what we want for our own kids: Access to exceptional, effective mental and behavioral health care online that helps every young mind achieve its greatest potential.  Based in Colorado, HYM accepts Medicaid, private pay, Kaiser of Colorado and Cigna/Evernorth.  HYM provides the following services: Counseling, Testing and Evaluation, Speech and Language Therapy, Occupational Therapy, Art Therapy, Behavioral Therapy, Music Therapy and Forensic Evaluations and has licensed providers who can begin to treat kids from across our state immediately.  View our flyer in English and Spanish. Learn more by visiting HYM’s website here, or call or email Julie Norman, HYM’s lead therapist at 303-317-6504 or julie@healthyyoungminds.com.

Mead Johnson develops and markets safe, high-quality, innovative products that help meet the nutritional needs of infants and children. With more than 70 products in over 50 countries, Mead Johnson products are trusted by millions of parents and healthcare professionals around the world. Learn more by visiting here, and with a mobile device, you can download the Mead Johnson Pediatric Product Guide App. Contact: Julie Smith, MSRDN, Julie.smith@reckitt.com, 774-273-0899

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information contact Lori Amels at LAmels@sarepta.com, 559-287-2221, or visit www.sarepta.com.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company; our passion and pursuit of potentially life-changing treatments are rooted in our history. We know patients with rare diseases have spent their lives overcoming challenges. That’s why for 70+ years we’ve been working to support them in their fight. To learn more visit www.takeda.com or contact Jennifer.oberly@takeda.com or phone at (303) 802-0472.

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). To learn more visit www.takeda.com or contact tawnie.houtchens@takeda.com or phone at 720.518.7117.